Mediators of inflammation and their effect on resident renal cells: Implications in lupus nephritis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Yung, Susan ^a   Cheung, Kwok Fan ^a   Zhang, Qing ^a   Chan, Tak Mao ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HYALURONIC ACID; IMMUNOGLOBULIN G ANTIBODY; INFLIXIMAB; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; INTERFERON;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; APOPTOSIS; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; CYTOPLASM; DISEASE ACTIVITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; INTERNALIZATION; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; HUMANS; HYALURONIC ACID; INFLAMMATION MEDIATORS; INTERFERON TYPE I; INTERLEUKIN-6; LUPUS NEPHRITIS; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885648566     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/317682     Document Type: Review

References (120)

1. Cameron J. S., Lupus nephritis. Journal of the American Society of Nephrology 1999 10 2 413 424 2-s2.0-0032938545 (Pubitemid 29068083)
2. Vlahakos D., Foster M. H., Ucci A. A., Barrett K. J., Datta S. K., Madaio M. P., Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. Journal of the American Society of Nephrology 1992 2 8 1345 1354 2-s2.0-0026814959
3. Isenberg D. A., Manson J. J., Ehrenstein M. R., Rahman A., Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology 2007 46 7 1052 1056 2-s2.0-34447320202 10.1093/rheumatology/kem112 (Pubitemid 47050602)
4. Hahn B. H., Antibodies to DNA. The New England Journal of Medicine 1998 338 19 1359 1368 2-s2.0-0032493059 10.1056/NEJM199805073381906 (Pubitemid 28216666)
5. Yu C.-L., Huang M.-H., Tsai C.-Y., Tsai Y.-Y., Tsai S.-T., Sun K.-H., Han S.-H., Yu H.-S., The effect of human polyclonal anti-dsDNA autoantibodies on apoptotic gene expression in cultured rat glomerular mesangial cells. Scandinavian Journal of Rheumatology 1998 27 1 54 60 2-s2.0-0031929999 10.1080/030097498441182 (Pubitemid 28116471)
6. Chan T., Leung J. K., Ho S. K., Yung S., Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. Journal of the American Society of Nephrology 2002 13 5 1219 1229 2-s2.0-0036232276 10.1097/01.ASN.0000014223.71109.13 (Pubitemid 34441402)
7. Yung S., Tsang R. C. W., Leung J. K. H., Chan T. M., Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1 β Kidney International 2006 69 2 272 280 2-s2.0-33644661974 10.1038/sj.ki.5000042 (Pubitemid 43323077)
8. Yung S., Chan T. M., Anti-DNA antibodies in the pathogenesis of lupus nephritis-the emerging mechanisms. Autoimmunity Reviews 2008 7 4 317 321 2-s2.0-39549111438 10.1016/j.autrev.2007.12.001
9. Yung S., Zhang Q., Chen Z. Z., Kwok W. C., Sing L. L., Tak M. C., Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis and Rheumatism 2009 60 7 2071 2082 2-s2.0-67650065024 10.1002/art.24573
10. Yung S., Cheung K. F., Zhang Q., Chan T. M., Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. Journal of the American Society of Nephrology 2010 21 11 1912 1927 2-s2.0-78149305875 10.1681/ASN.2009080805
11. Chan T. M., Frampton G., Staines N. A., Hobby P., Perry G. J., Cameron J. S., Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clinical and Experimental Immunology 1992 88 1 68 74 2-s2.0-0026597719
12. Chan T. M., Yu P. M., Tsang K. L. C., Cheng I. K. P., Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations. Clinical and Experimental Immunology 1995 100 3 506 513 2-s2.0-0029004164
13. Lai K. N., Leung J. C., Bik Lai K., Li P. K., Lai C. K., Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from endothelial cells. Journal of Pathology 1996 178 4 451 457 (Pubitemid 26145139)
14. Lai K. N., Leung J. C. K., Lai K. B., Lai C. K. W., Effect of anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor- β and nitric oxide synthase in cultured endothelial cells. Scandinavian Journal of Rheumatology 1997 26 6 461 467 2-s2.0-0031452106 (Pubitemid 28005051)
15. Mostoslavsky G., Fischel R., Yachimovich N., Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. European Journal of Immunology 2001 31 4 1221 1227
16. Deocharan B., Qing X., Lichauco J., Putterman C. Actinin is a cross-reactive renal target for pathogenic anti-DNA aptibodies. Journal of Immunology 2002 168 6 3072 3078 2-s2.0-0037087262 (Pubitemid 34211690)
17. Kalaaji M., Mortensen E., Jørgensen L., Olsen R., Rekvig O. P., Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. American Journal of Pathology 2006 168 6 1779 1792 2-s2.0-33744756400 10.2353/ajpath.2006.051329 (Pubitemid 43825300)
18. Davas E. M., Tsirogianni A., Kappou I., Karamitsos D., Economidou I., Dantis P. C., Serum IL-6, TNF p55 srTNF p75 srTNF srIL-2 levels and disease activity in systemic lupus erythematosus. Clinical Rheumatology 1999 18 1 17 22 2-s2.0-0033005853 10.1007/s100670050045 (Pubitemid 29104747)
19. Gigante A., Gasperini M. L., Afeltra A., Barbano B., Margiotta D., Cianci R., De Francesco I., Amoroso A., Cytokines expression in SLE nephritis. European Review for Medical and Pharmacological Sciences 2011 15 1 15 24 2-s2.0-79953159474
20. Herrera-Esparza R., Barbosa-Cisneros O., Villalobos-Hurtado R., Avalos-Díaz E., Renal expression of IL-6 and TNF genes in lupus nephritis. Lupus 1998 7 3 154 158 2-s2.0-0031939179 10.1191/096120398678919949 (Pubitemid 28190678)
21. Ryffel B., Car B. D., Gunn H., Roman D., Hiestand P., Mihatsch M. J., Interleukin-6 exacerbates glomerulonephritis in (NZBxNZW)F1 mice. American Journal of Pathology 1994 144 5 927 937 2-s2.0-0028355713
22. Pramanik R., Jørgensen T. N., Xin H., Kotzin B. L., Choubey D., Interleukin-6 Induces Expression of Ifi202, an Interferon-inducible Candidate Gene for Lupus Susceptibility. The Journal of Biological Chemistry 2004 279 16 16121 16127 2-s2.0-1942533545 10.1074/jbc.M313140200 (Pubitemid 38509303)
23. Liu Z., Bethunaickan R., Huang W., Ramanujam M., Madaio M. P., Davidson A., IFN-confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. Journal of Immunology 2011 187 3 1506 1513 2-s2.0-80051616991 10.4049/jimmunol.1004142
24. Malide D., Russo P., Bendayan M., Presence of tumor necrosis factor and interleukin-6 in renal mesangial cells of lupus nephritis patients. Human Pathology 1995 26 5 558 564 2-s2.0-0029020289
25. Beck-Schimmer B., Oertli B., Pasch T., Wüthrich R. P., Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. Journal of the American Society of Nephrology 1998 9 12 2283 2290 2-s2.0-0031755720 (Pubitemid 28543806)
26. Terrier B., Costedoat-Chalumeau N., Garrido M., Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus. Journal of Rheumatology 2012 39 9 1819 1828
27. Okamoto A., Fujio K., Tsuno N. H., Takahashi K., Yamamoto K., Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney International 2012 82 9 969 979
28. Kuroiwa T., Lee E. G., Cellular interactions in the pathogenesis of lupus nephritis: the role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 1998 7 9 597 603 2-s2.0-0032427023 10.1191/096120398678920712 (Pubitemid 29008225)
29. Banchereau J., Pascual V., Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006 25 3 383 392 2-s2.0-33748447541 10.1016/j.immuni.2006.08.010 (Pubitemid 44354221)
30. Chen J., Hartono J. R., John R., Bennett M., Zhou X. J., Wang Y., Wu Q., Winterberg P. D., Nagami G. T., Lu C. Y., Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney international 2011 80 5 504 515 2-s2.0-84857096395
31. Sun K.-H., Yu C.-L., Tang S.-J., Sun G.-H., Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1 β IL-6, IL-8, IL-10 and TNF- from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 2000 99 3 352 360 2-s2.0-0034094660 10.1046/j.1365-2567.2000.00970.x (Pubitemid 30137699)
32. Baer P. C., Wegner B., Geiger H., Effects of mycophenolic acid on IL-6 expression of human renal proximal and distal tubular cells in vitro. Nephrology Dialysis Transplantation 2004 19 1 47 52 2-s2.0-0347286849 10.1093/ndt/gfg429 (Pubitemid 38072614)
33. Yung S., Tsang R. C. W., Sun Y., Leung J. K. H., Chan T. M., Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. Journal of the American Society of Nephrology 2005 16 11 3281 3294 2-s2.0-33644878084 10.1681/ASN.2004110917 (Pubitemid 46179333)
34. Taflin C., Favier B., Baudhuin J., Savenay A., Hemon P., Bensussan A., Charron D., Glotz D., Mooney N., Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proceedings of the National Academy of Sciences of the United States of America 2011 108 7 2891 2896 2-s2.0-79952602026 10.1073/pnas.1011811108
35. Chiu Y., Lin C., Chen C., Huang K., Tong K., Tzeng C., Lee T., Hsu H., Tang C., Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1- dependent pathway. Journal of Immunology 2009 183 4 2785 2792 2-s2.0-70149085910 10.4049/jimmunol.0802826
36. Antonelli A., Ferri C., Ferrari S. M., Mancusi C., Colaci M., Sebastiani M., Fallahi P., IFN- γ and TNF-induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. Scandinavian Journal of Rheumatology 2011 40 6 453 456 2-s2.0-83455210338 10.3109/03009742.2011.585349
37. Iwano M., Dohi K., Hirata E., Kurumatani N., Horii L. Y., Shiiki H., Fukatsu A., Matsuda T., Hirano T., Kishimoto T., Ishikawa H., Urinary levels of IL-6 in patients with active lupus nephritis. Clinical Nephrology 1993 40 1 16 21 2-s2.0-0027237857 (Pubitemid 23221728)
38. Fukatsu A., Matsuo S., Tamai H., Sakamoto N., Matsuda T., Hirano T., Distribution of interleukin-6 in normal and diseased human kidney. Laboratory Investigation 1991 65 1 61 66 2-s2.0-0025815595
39. Yu C.-L., Sun K.-H., Tsai C.-Y., Hsieh S.-C., Yu H.-S., Anti-dsDNA antibody up-regulates interleukin 6, but not cyclo-oxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? Inflammation Research 2001 50 1 12 18 2-s2.0-0035138056 10.1007/s000110050718 (Pubitemid 32162127)
40. Nath K. A., Tubulointerstitial changes as a major determinant in the progression of renal damage. American Journal of Kidney Diseases 1992 20 1 1 17 2-s2.0-0026769228
41. Ryan M. J., Johnson G., Kirk J., Fuerstenberg S. M., Zager R. A., Torok-Storb B., HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney International 1994 45 1 48 57 2-s2.0-0028010818 (Pubitemid 24045991)
42. Yurasov S., Tiller T., Tsuiji M., Velinzon K., Pascual V., Wardemann H., Nussenzweig M. C., Persistent expression of autoantibodies in SLE patients in remission. Journal of Experimental Medicine 2006 203 10 2255 2261 2-s2.0-33749349457 10.1084/jem.20061446 (Pubitemid 44498360)
43. Ronda N., Cravedi P., Benozzi L., Lunghi P., Bonati A., Allegri L., Carnevali M. L., Caserta C., Borghetti A., Buzio C., Early proinflammatory activation of renal tubular cells by normal and pathologic IgG. Nephron-Experimental Nephrology 2005 100 2 e77 e84 2-s2.0-20944448271 10.1159/000084573 (Pubitemid 40868655)
44. Allison A. C., Eugui E. M., Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000 47 2-3 85 118 2-s2.0-0034045586 10.1016/S0162-3109(00)00188-0 (Pubitemid 30394534)
45. Chan T. M., Li F. K., Tang C. S. O., Wong R. W. S., Fang G. X., Ji Y. L., Lau C. S., Wong A. K. M., Tong M. K. L., Chan K. W., Lai K. N., Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. The New England Journal of Medicine 2000 343 16 1156 1162 2-s2.0-0034687429 10.1056/NEJM200010193431604
46. Chan T., Tse K., Tang C. S., Mok M., Li F., Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. Journal of the American Society of Nephrology 2005 16 4 1076 1084 2-s2.0-20444466207 10.1681/ASN.2004080686 (Pubitemid 41710318)
47. Ginzler E. M., Dooley M. A., Aranow C., Kim M. Y., Buyon J., Merrill J. T., Petri M., Gilkeson G. S., Wallace D. J., Weisman M. H., Appel G. B., Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. The New England Journal of Medicine 2005 353 21 2219 2228 2-s2.0-28144433147 10.1056/NEJMoa043731 (Pubitemid 41697285)
48. Huang Y., Liu Z., Huang H., Liu H., Li L., Effects of mycophenolic acid on endothelial cells. International Immunopharmacology 2005 5 6 1029 1039 2-s2.0-17044393532 10.1016/j.intimp.2005.01.015
49. Park J., Chang H. K., Ha H., Kim M. S., Ahn H. J., Kim Y. S., Mycophenolic acid inhibits cell proliferation and extracellular matrix synthesis in rat vascular smooth muscle cells through direct and indirect inhibition of cellular reactive oxygen species. Journal of Surgical Research 2008 150 1 17 23 2-s2.0-53449100970 10.1016/j.jss.2007.09.011
50. Hauser I. A., Renders L., Radeke H., Sterzel R. B., Goppelt-Struebe M., Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrology Dialysis Transplantation 1999 14 1 58 63 2-s2.0-0032894546 10.1093/ndt/14.1.58 (Pubitemid 29041868)
51. Morath C., Reuter H., Simon V., Krautkramer E., Muranyi W., Schwenger V., Goulimari P., Grosse R., Hahn M., Lichter P., Zeier M., Effects of mycophenolic acid on human fibroblast proliferation, migration and adhesion in vitro and in vivo. American Journal of Transplantation 2008 8 9 1786 1797 2-s2.0-49649106988 10.1111/j.1600-6143.2008.02322.x
52. Chang H., Wu V., Wu K., Huang H., Hsieh B., Chen Y., In rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-. British Journal of Pharmacology 2010 160 7 1611 1620 2-s2.0-77954324864 10.1111/j.1476-5381.2010. 00837.x
53. Dubus I., Vendrely B., Christophe I., Labouyrie J., Delmas Y., Bonnet J., Combe C., Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney International 2002 62 3 857 867 2-s2.0-0036424451 10.1046/j.1523-1755.2002.00514.x (Pubitemid 35316714)
54. Finck B. K., Chan B., Wofsy D., Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. Journal of Clinical Investigation 1994 94 2 585 591 2-s2.0-0027930909 (Pubitemid 24250987)
55. Kiberd B. A., Interleukin-6 receptor blockage ameliorates murine lupus nephritis. Journal of the American Society of Nephrology 1993 4 1 58 61 2-s2.0-0027631201
56. Liang B., Gardner D. B., Griswold D. E., Bugelski P. J., Song X. Y. R., Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology 2006 119 3 296 305 2-s2.0-33750011260 10.1111/j.1365-2567.2006.02433.x (Pubitemid 44571047)
57. Cash H., Relle M., Menke J., Brochhausen C., Jones S. A., Topley N., Galle P. R., Schwarting A., Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Fas lpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Journal of Rheumatology 2010 37 1 60 70 2-s2.0-73649123508 10.3899/jrheum.090194
58. Black R. A., Rauch C. T., Kozlosky C. J., Peschon J. J., Slack J. L., Wolfson M. F., Castner B. J., Stocking K. L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K. A., Gerhart M., Davis R., Fitzner J. N., Johnson R. S., Paxton R. J., March C. J., Cerretti D. P., A metalloproteinase disintegrin that releases tumour-necrosis factor-from cells. Nature 1997 385 6618 729 733 2-s2.0-8044257704 10.1038/385729a0 (Pubitemid 27098094)
59. Boswell J. M., Yui M. A., Burt D. W., Kelley V. E., Increased tumor necrosis factor and IL-1 β gene expression in the kidneys of mice with lupus nephritis. Journal of Immunology 1988 141 9 3050 3054 2-s2.0-0023732974
60. Maury C. P. J., Teppo A.-M., Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis and Rheumatism 1989 32 2 146 150 2-s2.0-0024505250 (Pubitemid 19056401)
61. Aringerl M., Feierl E., Steiner G., Stummvoll G. H., Höfler E., Steiner C. W., Radda I., Smolen J. S., Graninger W. B., Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death. Lupus 2002 11 2 102 108 2-s2.0-0036206671 10.1191/0961203302lu160oa (Pubitemid 34259440)
62. Brennan D. C., Yui M. A., Wuthrich R. P., Kelley V. E., Tumor necrosis factor and IL-1 in New Zealand black/white mice. Enhanced gene expression and acceleration of renal injury. Journal of Immunology 1989 143 11 3470 3475 2-s2.0-0024330731 (Pubitemid 20007007)
63. Wallach D., Holtmann H., Engelmann H., Nophar Y., Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. Journal of Immunology 1988 140 9 2994 2999 2-s2.0-0023926860
64. Jacob C. O., McDevitt H. O., Tumour necrosis factor-in murine autoimmune 'lupus' nephritis. Nature 1988 331 6154 356 358 2-s2.0-0023874728 (Pubitemid 18042493)
65. Iwata Y., Wada T., Furuichi K., Sakai N., Matsushima K., Yokoyama H., Kobayashi K., p38 mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Faslpr mice. Journal of the American Society of Nephrology 2003 14 1 57 67 2-s2.0-0037218943 10.1097/01.ASN.0000037402.83851.5F (Pubitemid 36026297)
66. Aringer M., Houssiau F., Gordon C., Graninger W. B., Voll R. E., Rath E., Steiner G., Smolen J. S., Adverse events and efficacy of TNF-blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology 2009 48 11 1451 1454 2-s2.0-73349117550
67. Aringer M., Steiner G., Graninger W. B., Höfler E., Steiner C. W., Smolen J. S., Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis and Rheumatism 2007 56 1 274 279 2-s2.0-33846231376 10.1002/art.22327 (Pubitemid 46106201)
68. Charles P. J., Smeenk R. J., De Jong J., Feldmann M., Maini R. N., Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor: findings in open-label and randomized placebo-controlled trials. Arthritis and Rheumatism 2000 43 11 2383 2390
69. De Rycke L., Baeten D., Kruithof E., Van Den Bosch F., Veys E. M., De Keyser F., The effect of TNF blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 2005 14 12 931 937 2-s2.0-30644474299 10.1191/0961203305lu2240rr (Pubitemid 43088266)
70. Stokes M. B., Foster K., Markowitz G. S., Ebrahimi F., Hines W., Kaufman D., Moore B., Wolde D., D'Agati V. D., Development of glomerulonephritis during anti-TNF-; therapy for rheumatoid arthritis. Nephrology Dialysis Transplantation 2005 20 7 1400 1406 2-s2.0-26044483813 10.1093/ndt/gfh832 (Pubitemid 41430613)
71. Bethunaickan R., Sahu R., Liu Z., Anti-tumor necrosis factor treatment of interferon-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. Arthritis and Rheumatism 2012 64 10 3399 3408
72. Davis L. S., Hutcheson J., Mohan C., The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus. Journal of Interferon and Cytokine Research 2011 31 10 781 789 2-s2.0-80054709328 10.1089/jir.2011.0047
73. Ytterberg S. R., Schnitzer T. J., Serum interferon levels in patients with systemic lupus erythematosus. Arthritis and Rheumatism 1982 25 4 401 406 2-s2.0-0020026322 (Pubitemid 12158948)
74. Preble O. T., Black R. J., Friedman R. M., Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982 216 4544 429 431 2-s2.0-0019972228 (Pubitemid 12076067)
75. Ko K., Franek B. S., Marion M., Genetic ancestry, serum interferon-activity, and autoantibodies in systemic lupus erythematosus. Journal of Rheumatology 2012 39 6 1238 1240
76. Panem S., Ordonez N., Vilcek J., Renal deposition of interferon in systemic lupus erythematosus. Infection and Immunity 1983 42 1 368 373 2-s2.0-0020513378 (Pubitemid 13009852)
77. Niewold T. B., Hua J., Lehman T. J. A., Harley J. B., Crow M. K., High serum IFN-activity is a heritable risk factor for systemic lupus erythematosus. Genes and Immunity 2007 8 6 492 502 2-s2.0-34548438559 10.1038/sj.gene.6364408 (Pubitemid 47365615)
78. Qin L., Lv J., Zhou X., Hou P., Yang H., Zhang H., Association of IRF5 gene polymorphisms and lupus nephritis in a Chinese population. Nephrology 2010 15 7 710 713 2-s2.0-79952277766
79. Ronnblom L. E., Oberg K. E., Alm G. V., Possible induction of systemic lupus erythematosus by interferon-treatment in a patient with a malignant carcinoid tumour. Journal of Internal Medicine 1990 227 3 207 210 2-s2.0-0025057503 (Pubitemid 20075945)
80. Ehrenstein M. R., McSweeney E., Swana M., Worman C. P., Goldstone A. H., Isenberg D. A., Appearance of anti-DNA antibodies in patients treated with interferon-Arthritis and Rheumatism 1993 36 2 279 280 2-s2.0-0027511692 (Pubitemid 23059344)
81. Ioannou Y., Isenberg D. A., Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis and Rheumatism 2000 43 7 1431 1442 (Pubitemid 30452458)
82. Hägele H., Allam R., Pawar R. D., Reichel C. A., Krombach F., Anders H., Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. American Journal of Pathology 2009 175 5 1896 1904 2-s2.0-73649094099 10.2353/ajpath.2009.090182
83. Patole P. S., Gröne H., Segerer S., Ciubar R., Belemezova E., Henger A., Kretzler M., Schlöndorff D., Anders H., Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. Journal of the American Society of Nephrology 2005 16 5 1326 1338 2-s2.0-23944497673 10.1681/ASN.2004100820 (Pubitemid 41716517)
84. Flür K., Allam R., Zecher D., Kulkarni O. P., Lichtnekert J., Schwarz M., Beutler B., Vielhauer V., Anders H., Viral RNA induces type i interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: implications for viral infection-associated glomerulonephritis. American Journal of Pathology 2009 175 5 2014 2022 2-s2.0-73649090376 10.2353/ajpath.2009.080585
85. Fairhurst A., Xie C., Fu Y., Wang A., Boudreaux C., Zhou X. J., Cibotti R., Coyle A., Connolly J. E., Wakeland E. K., Mohan C., Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. Journal of Immunology 2009 183 10 6831 6838 2-s2.0-77649245893 10.4049/jimmunol.0900742
86. Ramanujam M., Kahn P., Huang W., Tao H., Madaio M. P., Factor S. M., Davidson A., Interferon-treatment of Female (NZW × BXSB)F1 mice mimics some but not all features associated with the Yaa mutation. Arthritis and Rheumatism 2009 60 4 1096 1101 2-s2.0-65249143322 10.1002/art.24414
87. Mathian A., Weinberg A., Gallegos M., Banchereau J., Koutouzov S., IFN-induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White)F1 but not in BALB/c mice. Journal of Immunology 2005 174 5 2499 2506 2-s2.0-14044278824 (Pubitemid 40279662)
88. Santiago-Raber M., Baccala R., Haraldsson K. M., Choubey D., Stewart T. A., Kono D. H., Theofilopoulos A. N., Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. Journal of Experimental Medicine 2003 197 6 777 788 2-s2.0-0037451124 10.1084/jem.20021996 (Pubitemid 36350872)
89. Baechler E. C., Batliwalla F. M., Karypis G., Gaffney P. M., Ortmann W. A., Espe K. J., Shark K. B., Grande W. J., Hughes K. M., Kapur V., Gregersen P. K., Behrens T. W., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2610 2615 2-s2.0-0344492212 10.1073/pnas.0337679100 (Pubitemid 36297546)
90. Feng X., Wu H., Grossman J. M., Hanvivadhanakul P., FitzGerald J. D., Park G. S., Dong X., Chen W., Kim M. H., Weng H. H., Furst D. E., Gorn A., McMahon M., Taylor M., Brahn E., Hahn B. H., Tsao B. P., Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis and Rheumatism 2006 54 9 2951 2962 2-s2.0-33749331301 10.1002/art.22044 (Pubitemid 44497776)
91. Peterson K. S., Huang J., Zhu J., D'Agati V., Liu X., Miller N., Erlander M. G., Jackson M. R., Winchester R. J., Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. Journal of Clinical Investigation 2004 113 12 1722 1733 2-s2.0-3042844142 10.1172/JCI200419139 (Pubitemid 39071664)
92. Laurent T. C., Fraser J. R. E., Hyaluronan. The FASEB Journal 1992 6 7 2397 2404 2-s2.0-0026623391
93. Itano N., Kimata K., Mammalian hyaluronan synthases. IUBMB Life 2002 54 4 195 199 2-s2.0-0036819199 10.1080/15216540214929 (Pubitemid 36008328)
94. Toole B. P., Hyaluronan: from extracellular glue to pericellular cue. Nature Reviews Cancer 2004 4 7 528 539 2-s2.0-3042697038 (Pubitemid 38868622)
95. Hansell P., Goransson V., Odlind C., Gerdin B., Hallgren R., Hyaluronan content in the kidney in different states of body hydration. Kidney International 2000 58 5 2061 2068 2-s2.0-0033744405 10.1046/j.1523-1755.2000. 00378.x
96. Chan T. M., Tse W. W., Chau M., Yung S., Suppression of hyaluronan synthesis with 4-methylumbelliferone in NZB/W F1 mice is associated with reduced renal inflammation and renal function improvement. Journal of the American Society of Nephrology 2011 22 134A
97. Feusi E., Sun L., Sibalic A., Beck-Schimmer B., Oertli B., Wüthrich R. P., Enhanced hyaluronan synthesis in the MRL-Fas(lpr) kidney: role of cytokines. Nephron 1999 83 1 66 73 2-s2.0-0032841959 10.1159/000045475 (Pubitemid 29417649)
98. Ren J., Hascall V. C., Wang A., Cyclin D3 mediates synthesis of a hyaluronan matrix that is adhesive for monocytes in mesangial cells stimulated to divide in hyperglycemic medium. The Journal of Biological Chemistry 2009 284 24 16621 16632 2-s2.0-67650242385 10.1074/jbc.M806430200
99. Jones S., Jones S., Phillips A. O., Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney International 2001 59 5 1739 1749 2-s2.0-0035046380 10.1046/j.1523-1755. 2001.0590051739.x (Pubitemid 32336788)
100. Michael D. R., Phillips A. O., Krupa A., Martin J., Redman J. E., Altaher A., Neville R. D., Webber J., Kim M., Bowen T., The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell. The Journal of Biological Chemistry 2011 286 22 19523 19532 2-s2.0-79957588142 10.1074/jbc.M111.233916
101. Pedagogos E., Hewitson T. D., Nicholls K. M., Becker G. J., Hyaluronan and rat renal fibroblasts: in vitro studies. Nephron 2001 88 4 347 353 2-s2.0-0034944544 10.1159/000046019 (Pubitemid 32695891)
102. Takeda M., Babazono T., Nitta K., Iwamoto Y., High glucose stimulates hyaluronan production by renal interstitial fibroblasts through the protein kinase C and transforming growth factor- β cascade. Metabolism 2001 50 7 789 794 2-s2.0-0034924717 10.1053/meta.2001.24207 (Pubitemid 32700458)
103. Dane M. J., van den Berg B. M., Avramut M. C., Glomerular endothelial surface layer acts as a barrier against albumin filtration. American Journal of Pathology 2013 182 5 1532 1540
104. Wang A., Hascall V. C., Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. The Journal of Biological Chemistry 2004 279 11 10279 10285 2-s2.0-1642414046 10.1074/jbc.M312045200 (Pubitemid 38372634)
105. Selbi W., De La Motte C. A., Hascall V. C., Day A. J., Bowen T., Phillips A. O., Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney International 2006 70 7 1287 1295 2-s2.0-33748918920 10.1038/sj.ki.5001760 (Pubitemid 44435180)
106. Day A. J., De La Motte C. A., Hyaluronan cross-linking: a protective mechanism in inflammation? Trends in Immunology 2005 26 12 637 643 2-s2.0-27744571610 10.1016/j.it.2005.09.009 (Pubitemid 41628196)
107. Chan T. M., Tsang R. C. W., Chan K. W., Yung S., Anti-DNA antibodies stimulate hyaluronan synthesis in proximal tubular epithelial cells through the induction of IL-6 and IL-1b. Journal of the American Society of Nephrology 2006 17 352A
108. McKee C. M., Penno M. B., Cowman M., Burdick M. D., Strieter R. M., Bao C., Noble P. W., Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. Journal of Clinical Investigation 1996 98 10 2403 2413 2-s2.0-0029808003 (Pubitemid 26394217)
109. Jiang D., Liang J., Noble P. W., Hyaluronan in tissue injury and repair. Annual Review of Cell and Developmental Biology 2007 23 435 461 2-s2.0-38049066579 10.1146/annurev.cellbio.23.090506.123337
110. Jiang D., Liang J., Noble P. W., Hyaluronan as an immune regulator in human diseases. Physiological Reviews 2011 91 1 221 264 2-s2.0-78751670809 10.1152/physrev.00052.2009
111. Yung S., Chan T. M., The role of hyaluronan and CD44 in the pathogenesis of lupus nephritis. Autoimmune Diseases 2012 2012 9 207190 10.1155/2012/207190
112. Collins S. L., Black K. E., Chan-Li Y., Ahn Y., Cole P. A., Powell J. D., Horton M. R., Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor. American Journal of Respiratory Cell and Molecular Biology 2011 45 4 675 683 2-s2.0-80053644689 10.1165/rcmb.2010-0387OC
113. Haslinger B., Mandl-Weber S., Sellmayer A., Sitter T., Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell and Tissue Research 2001 305 1 79 86 2-s2.0-0034923198 10.1007/s004410100409 (Pubitemid 32681870)
114. Benz P. S., Fan X., Wüthrich R. P., Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Kidney International 1996 50 1 156 163 2-s2.0-0029831605 (Pubitemid 26323709)
115. Pérez de Lema G., Maier H., Nieto E., Vielhauer V., Luckow B., Mampaso F., Schlondorff D., Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. Journal of the American Society of Nephrology 2001 12 7 1369 1382 2-s2.0-0034917006 (Pubitemid 32666320)
116. Tesch G. H., Maifert S., Schwarting A., Rollins B. J., Kelley V. R., Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. Journal of Experimental Medicine 1999 190 12 1813 1824 2-s2.0-0033402848 10.1084/jem.190.12.1813 (Pubitemid 30013847)
117. Göransson V., Johnsson C., Jacobson A., Heldin P., Hällgren R., Hansell P., Renal hyalurona accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat. Nephrology Dialysis Transplantation 2004 19 4 823 830 2-s2.0-1842523228 10.1093/ndt/gfh003 (Pubitemid 38455652)
118. Woodrow G., Turney J. H., Davison A. M., Cooper E. H., Serum hyaluronan concentrations predict survival in patients with chronic renal failure on maintenance haemodialysis. Nephrology Dialysis Transplantation 1996 11 1 98 100 2-s2.0-0030040338 (Pubitemid 26038472)
119. Pecoits-Filho R., Heimbürger O., Bárány P., Suliman M., Fehrman-Ekholm I., Lindholm B., Stenvinkel P., Associations between circulating inflammatory markers and residual renal function in CRF patients. American Journal of Kidney Diseases 2003 41 6 1212 1218 2-s2.0-0038100467 10.1016/S0272-6386(03)00353-6 (Pubitemid 36637976)
120. Stenvinkel P., Heimburger O., Wang T., Lindholm B., Bergstrom J., Elinder C.- G., High serum hyaluronan indicates poor survival in renal replacement therapy. American Journal of Kidney Diseases 1999 34 6 1083 1088 2-s2.0-0032694169